Comparison of pretreatment characteristics and treatment outcomes for alcohol-, cocaine- and multisubstance-dependant patients

A. A. PATKAR ; C. C. THORNTON ; P. MANNELLI ; K. P. HILL ; E. GOTTHEIL ; M. J. VERGARE ; S. P. WEINSTEIN | 2004
Périodique

ENGLISH : We investigated whether pretreatment characteristics and measures of outcome differed for alcohol-, cocaine-, and multisubstance-dependent patients receiving outpatient substance abuse treatment. One hundred and forty substance depen[...]

Plus d'info

Ajouter à la sélection

Medical cannabis [JAMA Patient Page]

K. P. HILL | 2020
Dans Journal of the American Medical Association (Vol.323, n°6, February 11, 2020) Article : Périodique

Medical cannabis refers to preparations of the cannabis plant that patients use to treat medical conditions. The cannabis plant has been used for medicinal purposes for thousands of years by many civilizations. As of January 2020, 33 states and[...]

Plus d'info

Ajouter à la sélection

Lien externe

Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review

K. P. HILL | 2015
Dans Journal of the American Medical Association (Vol.313, n°24, June 23/30, 2015) Article : Périodique

Importance: As of March 2015, 23 states and the District of Columbia had medical marijuana laws in place. Physicians should know both the scientific rationale and the practical implications for medical marijuana laws. Objective: To review the p[...]

Plus d'info

Ajouter à la sélection

Medical use of cannabis in 2019

K. P. HILL | 2019
Dans Journal of the American Medical Association (Vol.322, n°10, September 10, 2019) Article : Périodique

Nearly 10% of cannabis users in the United States report using it for medicinal purposes. As of August 2019, 33 states and the District of Columbia have initiated policies allowing the use of cannabis or cannabinoids for the management of specif[...]

Plus d'info

Ajouter à la sélection

Lien externe

Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures

A. A. PATKAR ; C. C. THORNTON ; W. H. BERRETTINI ; E. GOTTHEIL ; S. P. WEINSTEIN ; K. P. HILL | 2002
Périodique

ENGLISH : We investigated whether urine drug screens (UDS) at admission and platelet paroxetine binding, a measure of serotonin transporter sites, were related to outcome measures for cocaine patients in treatment. Tritiated paroxetine binding[...]

Plus d'info

Ajouter à la sélection

Relationship between platelet serotonin uptake sites and measures of impulsivity, agression, and craving among african-american cocaine abusers

A. A. PATKAR ; E. GOTTHEIL ; W. H. BERRETTINI ; K. P. HILL ; C. C. THORNTON ; S. P. WEINSTEIN | 2003
Périodique

We investigated whether platelet-tritiated paroxetine binding, a measure of serotonin uptake sites, and behavioral measures of impulsivity, aggression, and craving differed between cocaine-dependent subjects and controls and whether paroxetine b[...]

Plus d'info

Ajouter à la sélection

Relationship between platelet serotonin uptake sites and treatment outcome among african-american cocaine dependent individuals

A. A. PATKAR ; E. GOTTHEIL ; W. H. BERRETTINI ; C. C. THORNTON ; K. P. HILL ; S. P. WEINSTEIN | 2003
Périodique

ENGLISH : We investigated whether platelet tritiated paroxetine binding, a measure of serotonin uptake sites differed between cocaine-dependent subjects and controls, and whether paroxetine binding was related to treatment-outcome for cocaine [...]

Plus d'info

Ajouter à la sélection

Serum prolactin and response to treatment among cocaine-dependent individuals

A. A. PATKAR ; K. P. HILL ; R. C. STERLING ; E. GOTTHEIL ; W. H. BERRETTINI ; S. P. WEINSTEIN | 2002
Périodique

ENGLISH : Considerable evidence indicates that dopaminergic mechanisms may modulate the central effects of cocaine. We investigated whether basal serum prolactin, a measure of central dopamine activity, differed between cocaine-dependent subje[...]

Plus d'info

Ajouter à la sélection